Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial-Reference-Cited by-同舟云学术

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial

Published:2014-08 Issue:9 Volume:15 Page:943-953
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Taal Walter,Oosterkamp Hendrika M,Walenkamp Annemiek M E,Dubbink Hendrikus J,Beerepoot Laurens V,Hanse Monique C J,Buter Jan,Honkoop Aafke H,Boerman Dolf,de Vos Filip Y F,Dinjens Winand N M,Enting Roelien H,Taphoorn Martin J B,van den Berkmortel Franchette W P J,Jansen Rob L H,Brandsma Dieta,Bromberg Jacoline E C,van Heuvel Irene,Vernhout René M,van der Holt Bronno,van den Bent Martin J

Funder

Roche Netherlands and by grant number DDHK

Publisher

Elsevier BV

Subject

Oncology

Reference37 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

3. Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma;Wick;J Clin Oncol,2010

4. Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma;Batchelor;J Clin Oncol,2013

5. Bevacizumab and CPT-11 in the treatment of relapsed malignant glioma;Stark-Vance;Neuro-oncol,2005

Cited by 612 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer;Journal of Controlled Release;2024-03

2. Amino acid PET vs. RANO MRI for prediction of overall survival in patients with recurrent high grade glioma under bevacizumab therapy;European Journal of Nuclear Medicine and Molecular Imaging;2024-01-17

3. A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial;BMC Cancer;2024-01-15

4. A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations;International Journal of Radiation Oncology*Biology*Physics;2024-01

5. Antiepileptic therapy algorithms in patients with primary and metastatic brain tumors;Russian Military Medical Academy Reports;2023-12-09